1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
    PLEASE HELP

Office of Drug Czar Representative to Speak at NABP Symposium on Medical Marijuana

  1. Terrapinzflyer
    Office of Drug Czar Representative to Speak at NABP Symposium on Medical Marijuana



    MOUNT PROSPECT, Ill., Oct. 21 /PRNewswire-USNewswire/ -- The National
    Association of Boards of Pharmacy(R) (NABP(R)) welcomes Office of National

    Drug Control Policy drug policy expert Kevin Sebat to speak at its 2009
    Symposium. On December 3, 2009, Sebat will discuss the current federal laws regarding marijuana as well as the recent policy shift regarding prosecution of medical marijuana cases in states that have legalized the practice.

    Symposium participants will learn how marijuana became a Schedule I controlled substance and the future of this status in light of recent policy shifts.

    The October 19 Department of Justice memo calls for a focus on prosecution of significant traffickers of illegal drugs and the disruption of illegal drug
    manufacturing and trafficking networks, rather than pursuing individuals whose actions comply with existing state and local laws providing for the medical use of marijuana. Currently, 14 states allow for the sale and use of medical marijuana including Alaska, California, Colorado, Hawaii, Maine, Maryland, Michigan, Montana, Nevada, New Mexico, Oregon, Rhode Island, Vermont, and Washington.

    This action represents a shift in drug prosecution policy to ensure the
    effective use of prosecutor and investigator resources; however, the
    Department of Justice memo states that it does not change the Controlled
    Substances Act which categorizes marijuana as a Schedule I controlled
    substance. Some advocates of medical marijuana see the move as a harbinger of the federal government recognizing the medicinal properties of marijuana.

    During the NABP Symposium, board of pharmacy members and other pharmacy stakeholders will spend a full day discussing the science behind medical marijuana, state regulations addressing its use, and the social and financial impact of the substance. Also discussed will be Canada's experience with national legalization of medical marijuana. Additionally, a panel of experts on both the pro and con sides will debate the issue of legalization.

    The NABP Symposium will be held December 3-4, 2009, at the J.W. Marriott Starr Pass Hotel in Tucson, AZ. Educational sessions held on December 4 will cover public-private partnership opportunities for boards of pharmacy.

    For a full description of the continuing pharmacy education sessions or to
    register for the 2009 Symposium, visit the Meetings section of the NABP Web site at http://www.nabp.net.


    NABP is the independent, international, and impartial Association that assists
    its member boards and jurisdictions in developing, implementing, and enforcing uniform standards for the purpose of protecting the public health.


    NABP and the NABP Foundation is accredited by the Accreditation Council for
    Pharmacy Education (ACPE) as a provider of continuing pharmacy education. ACPE Provider Number: 205. Participants may earn ACPE-approved continuing pharmacy education credit from NABP. Participants in continuing pharmacy education programs will receive credit by completing a "Statement of Continuing Pharmacy Education Participation" and submitting it to the NABP office. A validated Statement of Credit will be sent as proof of participation within approximately six weeks. Full attendance and completion of a program evaluation form for each session are required to receive continuing pharmacy education credit and a Statement of Credit.


    SOURCE National Association of Boards of Pharmacy
    http://www.reuters.com/article/pressRelease/idUS217261+21-Oct-2009+PRN20091021

Comments

To make a comment simply sign up and become a member!